News

Olema Oncology Announces New Preclinical Data for OP-3136 Demonstrating Anti-Tumor Activity in Multiple Solid Tumor Models at AACR 2025
Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies ...
Original-Research: PSI SE (von First Berlin Equity Research GmbH): Buy
You can download the research here: http://www.more-ir.de/d/32344.pdf E-Mail: [email protected] Archive at www.eqs-news.com ...
Clearmind Medicine Files International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders
Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to ...
TMC Welcomes U.S. Executive Order to Expedite Permitting and Evaluate Offtake of Critical Minerals from Nodules in the High Seas
TMC the metals company Inc. (Nasdaq: TMC) (“TMC” or the “Company”), an explorer of the world’s largest undeveloped resource of critical metals for building infrastructure, defense technologies, energy ...
Cogent Biosciences Presents Four Posters at the American Association for Cancer Research Annual Meeting 2025 and Announces Two New Leaders
Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced preclinical data from four pipeline ...
Altamira Therapeutics to Host Full Year 2024 Financial Results and Business Update Call on April 3 [...]
Altamira Therapeutics Ltd. ("Altamira" or the "Company") (OTCQB: CYTOF), a company dedicated to developing and commercializing RNA delivery technology for targets beyond the liver, today announced ...
Calidi Biotherapeutics Reports Inducement Grant Under NYSE American LLC Company Guide Section 711
Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, today announced that in connection ...
TopBuild Achieves 2025 Great Place to Work Certification for Third Consecutive Year
TopBuild Corp. (NYSE:BLD), a leading installer and specialty distributor of insulation and building material products to the construction industry in the United States and Canada, today announced that ...
Original-Research: Warimpex Finanz- und Beteiligungs AG (von East Value Resea...
Currently, the focus is on increasing occupancy rates and debt repayment. Although we had previously accounted for the one-off loss of EUR 67.4m They now equal EUR 21.9m (prev. EUR 24.4m) for revenues ...
BlackRock® Canada Announces Final April Cash Distributions for the iShares® Premium Money Market ETF
BlackRock Asset Management Canada Limited (“BlackRock Canada”), an indirect, wholly-owned subsidiary of BlackRock, Inc. (NYSE: BLK), today announced the final April 2025 cash distributions for the ...
EnQuest Aktie: Fundamentale Stärken, schwache Performance
Die EnQuest-Aktie zeigt trotz solider Fundamentaldaten eine enttäuschende Kursentwicklung. Aktuell notiert das britische Öl- und Gasunternehmen bei 0,1631 Euro - ein Minus von 12,86 Prozent innerhalb ...